SCHEMBL21399698

SCHEMBL21399698

N#Cc1cccc(-n2c3ccccc3c3cc(C(F)(F)F)ccc32)c1-c1cc(C(F)(F)F)ccc1-n1c2ccccc2c2cc(C(F)(F)F)ccc21

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 2/20 0.38
HRH1 P35367 2/20 0.36
HTR6 P50406 2/20 0.36
TSHR P16473 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
PPARG P37231 2/20 0.34
PPARA Q07869 2/20 0.34
CNR2 P34972 1/20 0.34
RORC P51449 1/20 0.33
CYP3A4 P08684 1/20 0.33
PDK2 Q15119 1/20 0.33
AR P10275 2/20 0.33
FFAR2 O15552 1/20 0.32
ELANE P08246 1/20 0.32
MAPT P10636 1/20 0.32
MAPK10 P53779 1/20 0.32
KDM4E B2RXH2 1/20 0.32
HSP90AA1 P07900 1/20 0.32
CHRM4 P08173 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21399732 0.97 KIF11 (0.40) KIF11HRH1HTR6TSHRSMN1; SMN2
SCHEMBL21399497 0.96 PPARG (0.38) KIF11HRH1HTR6TSHRSMN1; SMN2
SCHEMBL21399695 0.95 TSHR (0.37) HRH1HTR6TSHRSMN1; SMN2CYP3A4
SCHEMBL21399697 0.94 KIF11 (0.35) KIF11HRH1HTR6TSHRSMN1; SMN2
SCHEMBL21399248 0.94 PPARG (0.36) KIF11HRH1HTR6TSHRSMN1; SMN2
SCHEMBL21399249 0.94 PPARG (0.36) KIF11HRH1HTR6TSHRSMN1; SMN2
SCHEMBL21399500 0.93 KIF11 (0.37) KIF11HRH1HTR6TSHRSMN1; SMN2
SCHEMBL21399246 0.92 SMN1; SMN2 (0.34) KIF11HRH1HTR6TSHRSMN1; SMN2
SCHEMBL21399303 0.92 PTPN5 (0.38) KIF11TSHRSMN1; SMN2CYP3A4AR
SCHEMBL21399502 0.91 TSHR (0.37) KIF11HRH1HTR6TSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190292151-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2019-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190292151-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, NR2E3, FOXO3 KIF11 4281/4885HRH1 2545/4885HTR6 1634/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.